Rectal and vaginal administration of insulin–chitosan formulations: An experimental study in rabbits

References

• Acartürk F. Preparation of a prolonged-release tablet formulation of diclofenac sodium. Part 1: Using chitosan. Die Pharmazie 1989; 44: 547–549
   PubMed Web of Science ®Google Scholar
• Acartürk F, Şencan A, Çelebi N. Evaluation of the effect of low molecular chitosan on the solubility and dissolution characteristics of spirinolactone. Die Pharmazie 1993a; 48: 605–608
   Web of Science ®Google Scholar
• Acartürk F, Şencan A, Çelebi N. Enhancement of the dissolution of spirinolactone with chitosan and low-molecular weight gelatin. STP Pharma Sci 1993b; 3: 369–373
   Google Scholar
• Ahsan F, Arnold JJ, Yang T, Meezan E, Schwiebert EM, Pillion DJ. Effects of the permeability enhancers, tetradecylmaltoside and dimethyl-β-cyclodextrin, on insulin movement across human bronchial epithelial cells (16HBE14o− ). Eur J Pharm Sci 2003; 20: 27–34
   PubMed Web of Science ®Google Scholar
• Akbuğa J, Durmaz G. Preparation and evaluation of cross-linked chitosan microspheres containing furosemide. Int J Pharm 1994; 111: 217–222
   Web of Science ®Google Scholar
• Artursson P, Lindmark T, Davis SS, Illum L. Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2). Pharm Res 1994; 11: 1358–1361
   PubMed Web of Science ®Google Scholar
• Aungst BJ, Rogers NJ, Shefter E. Comparison of nasal, rectal, buccal sublingual and intramuscular insulin efficacy and the effects of a bile salt absorption promoter. J Pharmacol Exp Ther 1988; 244: 23–27
   PubMed Web of Science ®Google Scholar
• Banga AK, Chien YW. Systemic delivery of therapeutic peptides and proteins. Int J Pharm 1988; 48: 15–50
   Web of Science ®Google Scholar
• Brange J, Langkjaer L. Insulin formulation and delivery. Protein delivery: Physical systems, Hendren Sanders. Plenium Press, New York 1997; 343–411
   Google Scholar
• Borchard G, Lueßen HL, De Boer AG, Verhoef JC, Lehr C, Junginger HE. The potential of mucoadhesive polymers in enhancing intestinal peptide drug absorption III. Effects of chitosan-glutamate and carbomer on epithelial tight junctions in vitro. J Control Rel 1996; 39: 131–138
   Web of Science ®Google Scholar
• Caldwell L, Nishihata T, Rytting JH, Higuchi T. Lymphatic uptake of water soluble drugs after rectal administration. J Pharm Pharmacol 1982; 34: 520–522
   PubMed Web of Science ®Google Scholar
• Degim IT, Acartürk F, Erdogan D, Demirez Lortlar N. Transdermal Administration of Bromocriptine. Biol Pharm Bull 2003; 26: 501–505
   PubMed Web of Science ®Google Scholar
• Dodane V, Amin Khan A, Mervin JR. Effect of chitosan on epithelial permeability and structure. Int J Pharm 1999; 182: 21–32
   PubMed Web of Science ®Google Scholar
• Dotsikas Y, Loukas YL. Kinetic degradation study of insulin complexed with methyl-beta cyclodextrin. Confirmation of complexation with electrospray mass spectrometry and 1 H NMR. J Pharm Biomed Anal 2002; 29: 487–494
   PubMed Web of Science ®Google Scholar
• Francis SA, Kelly JM, McCormack J, Rogers RA, Lai J, Schnecberger EE, Lynch RD. Rapid reduction of MDCK cell cholesterol by methyl-β-cyclodextrin alters steady state transepithelial electirical resistance. Eur J Cell Biol 1999; 78: 473–484
   PubMed Web of Science ®Google Scholar
• Heinemann L, Pfützner A, Heise T. Alternative routes of administration as an approach to improve insulin therapy: Update on dermal, oral, nasal and pulmonary insulin delivery. Curr Pharm Des 2001; 7: 1127–1351
   Web of Science ®Google Scholar
• Hovgaard L, Brondsted H, Nielsen HM. Drug delivery studies in caco-2 monolayers II. Absorption enhancer effects of lysophosphatdylcholines. Int J Pharm 1995; 114: 141–149
   Web of Science ®Google Scholar
• Hinchcliffe M, Illum L. Intranasal insulin delivery and therapy. Adv Drug Deliv Rev 1999; 35: 199–234
   PubMed Web of Science ®Google Scholar
• Hui-Bi X, Kai-Xun H, Yu-Shan Z, Qiu-Hua G, Qing-Zhi W, Wei-Qun T, Xi-Qun S, Ze-Xian C, Zhong-Hong G. Hypoglycaemic effect of a novel insulin buccal formulation on rabbits. Pharmacol Res 2002; 46: 459–467
   PubMed Web of Science ®Google Scholar
• Illum L, Davis SS. Intranasal insulin: Clinical pharmacokinetics. Clin Pharm 1992; 23: 30–41
   Google Scholar
• Ishihara M, Ono K, Sato M, Nakanishi K, Saito Y, Yura H, Matsui T, Hattori H, Fujita M, Kikuchi M, Kurita A. Acceleration of wound contraction and healing with a photocrosslinkable chitosan hydrogel. Wound Repair Regen 2001; 9: 513–521
   PubMed Web of Science ®Google Scholar
• Johansson F, Hjertberg E, Eirefelt S, Tronde A, Bengtsson UH. Mechanism for absorption enhancement of inhaled insulin by sodium taurocholate. Eur J Pharm Sci 2002; 17: 63–71
   PubMed Web of Science ®Google Scholar
• Jonker C, Hamman JH, Kotzé AF. Intestinal paracellular permeation enhancement with quaternised chitosan: In situ and in vitro evaluation. Int J Pharm 2002; 238: 205–213
   PubMed Web of Science ®Google Scholar
• Kasaai MR, Charlet G, Arul J. Master curve concentration dependence of semi-dilute solution viscosity of chitosan homologues: The Martin equation. Food Res Int 2000; 33: 63–67
   Web of Science ®Google Scholar
• Kahn CR, Shschter Y. Insulin, oral hypoglycaemic agents, and the pharmacology of the endocrine pancreas. The pharmacological basis of therapeutics, A Gilman, T Rall, A Nies, P Taylor. Pergamon Press, New York 1990; 1463–1495
   Google Scholar
• Kotzé AF, Lueßen HL, De Leeuw BJ, De Boer AG, Verhoef JC, Junginger HE. N-trimethyl chitosan chloride as a potential absorption enhancer across mucosal surfaces: In vitro evaluation in intestinal epithelial cells (Caco-2). Pharm Res 1997; 14: 1197–1202
   PubMed Web of Science ®Google Scholar
• Kotze AF, Thaou M, Verhoef JC, Junginger HE. Chitosan and N-trimethyl chitosan chloride as absorption enhancer for nasal and rectal delivery of insulin. Proc Int Symp Control Rel Bioact Mater 1998; 25: 479
   Google Scholar
• Kotzé AF, Lueßen HL, De Boer AG, Verhoef JC, Junginger HE. Chitosan for enhanced intestinal permeability: Prospects for derivatives soluble in neutral and basic environments. Eur J Pharm Sci 1999; 7: 145–151
   PubMed Web of Science ®Google Scholar
• Liversidge GG, Nishihata T, Engle KK, Higuchi T. Effect of suppository shape on the systemic availability of rectally administered insulin and sodium salicylate. Int J Pharm 1986; 30: 247–250
   Web of Science ®Google Scholar
• Mackay M, Phillips J, Hastewell J. Peptide drug delivery: Colonic and rectal absorption. Adv Drug Deliv Rev 1997; 28: 253–273
   Web of Science ®Google Scholar
• Matsubara K, Abe K, Irie T, Uekama K. Improvement of nasal bioavailability of luteinizing hormone-releasing hormone agonist, buserelin, by cyclodextrin derivatives in rats. J Pharm Sci 1995; 84: 1295–1300
   PubMed Web of Science ®Google Scholar
• Morimoto K, Takeeda T, Nakamoto Y, Morisaka K. Effective vaginal absorption of insulin in diabetic rats and rabbits using polyacrylic acid aqueous gel bases. Int J Pharm 1982; 12: 107–111
   Google Scholar
• Morishita M, Kajita M, Suzuki A, Takayama K, Chiba Y, Tokiwa S, Nagai T. The dose-related hypoglycemic effects of insulin emulsions incorporating highly purifie d EPA and DHA. Int J Pharm 2000; 201: 175–185
   PubMed Web of Science ®Google Scholar
• Muranishi S, Yamamoto A, Okada H. Rectal and vaginal absorption of peptides and proteins. Biological barriers to protein delivery, K Audus, T Raub. Plenium Press, New York and London 1993; 199–227
   Google Scholar
• Nishihata T, Rytting JH. Absorption-promoting adjuvants: Enhancing action on rectal absorption. Adv Drug Deliv Rev 1997; 28: 205–228
   Web of Science ®Google Scholar
• Rao SB, Sharma CP. Use of chitosan as a biomaterial: Studies on its safety and hemostatic potential. J Biomed Mater Res 1997; 34: 21–28
   PubMed Web of Science ®Google Scholar
• Richardson JL, Illum L. The vaginal route of peptide and protein drug delivery. Adv Drug Deliv Rev 1992; 8: 341–366
   Web of Science ®Google Scholar
• Richardson JL, Illum L, Thomas NW. Vaginal absorption of insulin in the rat: Effect of penetration enhancers on insulin uptake and mucosal histology. Pharm Res 1992a; 9: 878–883
   PubMed Web of Science ®Google Scholar
• Richardson JL, Farraj NF, Illum L. Enhanced vaginal absorption of insulin in sheep using lysophosphatidylcholine and a bioadhesive microsphere delivery system. Int J Pharm 1992b; 88: 319–325
   Web of Science ®Google Scholar
• Schipper NGM, Olsson S, Hoogstraate JA, De Boer AG, Varum KM, Artursson P. Chitosans as absorption enhancers for poorly absorbable drugs 2. Mechanism of absorption enhancement. Pharm Res 1997; 14: 923–929
   PubMed Web of Science ®Google Scholar
• Senel S, Hincal AA. Drug permeation enhancement via buccal route: Possibilities and limitations. J Control Rel 2001; 72: 133–144
   PubMed Web of Science ®Google Scholar
• Senel S, Kremer MJ, Wertz PW, Hill JR, Kas S, Hincal AA, Squier CA. Chitosan for intraoral peptide delivery. Chitosan in pharmacy and chemistry, RAA Muzzarelli, C Muzzarelli. Atec, Italy 2002; 77–84
   Google Scholar
• Siddiqui O, Chien YW. Nonparenteral administration of peptide and protein drugs. Crit Rev Ther Drug Carrier Syst 1987; 3: 195–208
   PubMed Web of Science ®Google Scholar
• Takayama K, Hirata M, Machida Y, Masada T, Sanan T, Nagai T. Effect of interpolymer complex formation on bioadhesive property and drug release phenomenon of compressed tablets consisting of chitosan hyaluronate. Chem Pharm Bull 1990; 38: 1993–1997
   PubMed Web of Science ®Google Scholar
• Tozaki H, Komoike J, Tada C, Maruyama T, Terabe A, Suzuki T, Yamamato A, Muranishi S. Chitosan capsules for colon-specific drug delivery: Improvement of insulin absorption from rat colon. J Pharm Sci 1997; 86: 1016–1021
   PubMed Web of Science ®Google Scholar
• Touitou E, Donbrow M, Azaz E. New hydrophilic vehicle enabling rectal and vaginal absorption of insulin, heparin, phenol red and gentamicin. J. Pharm. Pharmacol 1978; 30: 662–663
   PubMed Web of Science ®Google Scholar
• Van Der Lubben IM, Verhoef JC, Borchard G, Junginger HE. Chitosan and its derivatives in mucosal drug and vaccine delivery. Eur. J Pharm Sci 2001; 4: 201–207
   Web of Science ®Google Scholar
• Van der Merwe SM, Verhoef JC, Kotzé AF, Junginger HE. N-trimethyl chitosan chloride (TMC) as absorption enhancer in oral peptide drug delivery. Development and characterization of minitablet and granule formulations. Eur J Pharm Biopharm 2004; 57: 85–91
   PubMed Web of Science ®Google Scholar
• Ward PD, Tipin TK, Thakker DR. Enhancing paracellular permeability by modulating epithelial tight junctions. PSTT 2000; 3: 346–357
   PubMedGoogle Scholar
• Yamamoto A, Muranishi S. Rectal drug delivery systems improvement of rectal peptide absorption by absorption enhancers, protease inhibitors and chemical modification. Adv Drug Deliv Rev 1997; 28: 275–299
   Web of Science ®Google Scholar